References
Shaw LJ, Iskandrian AE. Prognostic value of gated myocardial perfusion SPECT. J Nucl Cardiol 2004;ll:171–85.
Berman DS, Hachamovitch R, Kiat H, Cohen I, Cabico JA, Wang FP, et al. Incremental value of prognostic testing in patients with known or suspected ischemic heart disease: a basis for optimal utilization of exercise technetium-99m sestamibi myocardial perfusion single photon computed tomography. J Am Coll Cardiol 1995;26:639–47.
Travin MI, Duca MD, Kline GM, Herman SD, Demus DD, Heller GV. Relation of gender to physician use of test results and to the prognostic value of stress technetium-99m sestamibi myocardial single-photon emission computed tomography scintigraphy. Am Heart J 1997;134:73–82.
Hachamovitch R, Berman DS, Kiat H, Bairy Merz CN, Cohen I, Cabico JA, et al. Effective risk stratification using exercise myocardial perfusion SPECT in women: gender-related differences in prognostic nuclear testing. J Am Coll Caidiol 1996;28:34–44.
Shaw L, Chaitman BR, Hilton TC, Stocke K, Younis LT, Caralis DG, et al. Prognostic value of dipyridamole thallium-201 imaging in elderly patients. J Am Coll Cardiol 1992; 19:1390–8.
Iskandrian AS, Heo J, Decoskey D, Askenase A, Segal BL. Use of exercise thallium-201 imaging for risk stratification of elderly patients with coronary artery disease. Am J Cardiol 1986;61:269–72.
Giri S, Shaw LJ, Murthy DR, Travin MI, Miller DD, Hachamovitch R, et al. Impact of diabetes on the risk stratification using stress single-photon emission computed tomography myocardial perfusion imaging in patients with symptoms suggestive of coronary artery disease. Circulation 2002;105:32–40.
Machecourt J, Longère P, Fagret D, Vanzetto G, Wolf JE, Polidori C, et al. Prognostic value of thallium-201 single-photon emission computed tomographic myocardial perfusion imaging according to the extent of myocardial defect. Study in 1026 patients with follow-up at 33 months. J Am Coll Caidiol 1994;23:1096–106.
Udelson JE, Shafer CD, Carrió I. Radionuclide imaging in heart failure: assessing etiology and outcomes and implications for management. J Nucl Cardiol 2002;9:S40–52.
Eagle KA, Coley CM, Newell JB, Brewster DC, Darling RC, Strauss HW, et al. Combining clinical and thallium data optimizes preoperative assessment of cardiac risk before major vascular surgery. Ann Intern Med 1989;110:859–66.
Stratmann HG, Younis LT, Wittry MD, Amato M, Miller DD. Exercise technetium-99m myocardial tomography for the risk stratification of men with medically treated unstable angina pectoris. Am J Caidiol 1995;76:236–40.
Gibson RS, Watson DD, Craddock GB, Crampton RS, Kaiser DL, Denny MJ, et al. Prediction of cardiac events after uncomplicated myocardial infarction: a prospective study comparing predischarge exercise thallium-201 scintigraphy and coronary angiography. Circulation 1983;68:321–36.
Travin MI, Dessouki A, Cameron T, Heller GV. Use of exercise technetium-99m sestamibi SPECT imaging to detect residual ischemia and for risk stratification following acute myocardial infarction. Am J Cardiol 1995;75:665–9.
Brown KA, Heller GV, Landin RS, Shaw LJ, Beller GA, Pasquale MJ, et al. Early dipyridamole 99m-Tc-sestamibi single photon emission computed tomographic imaging 2 to 4 days after acute myocardial infarction predicts in-hospital and postdischarge cardiac events: comparison with submaximal exercise imaging. Circulation 1999;100:2060–6.
Mahmarian JJ, Mahmarian AC, Marks GF, Pratt CM, Verani MS. Role of adenosine thallium-201 tomography for defining long-term risk in patients with acute myocardial infarction. J Am Coll Cardiol 1995;25:1330–40.
Verani MS. Should all patients undergo cardiac catheterization after a myocardial infarction? J Nucl Cardiol 1994; 1:S 134–46.
Mahmarian JJ, Dwivedi G, Lahiri T. Role of nuclear cardiac imaging in myocardial infarction: post infarction risk stratification. J Nucl Cardiol 2004; 11:186–209.
Elhendy A, Schinkel AFL, Van Domburg RT, Bax JJ, Valkema R, Poldermanns D. Rognostic value of stress 99m technetium tetro-fosmin SPECT in patients with old myocardial infarction. Impact of scintigraphic extent of coronary artery disease. J Nucl Cardiol 2004; 11:704–9.
Brown KA, Weiss RM, Clements JP, Wackers FJ. Usefulness of residual ischemic myocardium within prior infarct zone for identifying patients at high risk late after acute myocardial infarction. Am J Cardiol 1987;60:15–9.
Zellweger MJ, Dubois EA, Lai S, Shaw LJ, Amanullah AM, Lewin HC, et al. Risk stratification in patients with remote prior myocardial infarction using rest-stress myocardial perfusion SPECT: prognostic value and impact on referral to early catheterization. J Nucl Cardiol 2002;9:23–32.
Sarda L, Colin P, Boccara F, Daou D, Lebtahi R, Faraggi M, et al. Myocarditis in patients with clinical presentation of myocardial infarction and normal coronary angiograms. J Am Coll Cardiol 2001;37:786–92.
Hansen CL, Crabbe D, Rubin S. Lower diagnostic accuracy of thallium 201 SPECT myocardial perfusion imaging in women: an effect of smaller chamber size. J Am Coll Cardiol 1996;28:1214–9.
Risk stratification and survival after myocardial infarction. Multi-center post-infarction research group. N Engl J Med 1982;306:1065–70.
Deedwania PC, Amsterdam EA, Vagelos RH. Evidence-based, cost-effective risk stratification and management after myocardial infarction. Arch Intern Med 1997;157:273–80.
Peterson ED, Shaw LJ, Califf RM. Risk stratification after myocardial infarction. Ann Intern Med 1997;126:556–60.
Travin MI, Heller GV, Johnson LL, Katten D, Ahlberg AW, Isasi CR, et al. The prognostic value of ECG-gated SPECT imaging in patients undergoing stress Tc-99m sestamibi myocardial perfusion imaging. J Nucl Cardiol 2004; 11:253–62.
Sharir T, Germano G, Kang X, Lewin HC, Miranda R, Cohen R, et al. Prediction of myocardial infarction versus cardiac death by gated myocardial perfusion SPECT: risk stratification by the amount of stress-induced ischemia and the poststress ejection fraction. J Nucl Med 2001 ;42:831–7.
Allman KC, Shaw LJ, Hachamovitch R, Udelson JE. Myocardial viability testing and impact of revascularization on prognosis in patients with coronary artery disease and left ventricular dysfunction: a meta-analysis. J Am Coll Cardiol 2002;39:l 151–8.
Moss AJ, Zareba W, Hall WJ, Klein H, Wilber DJ, Cannom DS, et al. Multicenter Automatic Defibrillator Implantation Trial II Investigators. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 2002;346:877–83.
Bristow MR, Saxon LA, Boehmer J, Krueger S, Kass DA, DeMarco T, et al, Comparison of Medical Therapy, Pacing, and Defibrillation in Heart Failure (COMPANION) Investigators. Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced heart failure. N Engl J Med 2004;350:2140–50.
Hachamovitch R, Hayes S, Friedman JD, Cohen I, Shaw LJ, Germans G, et al. Determinants of risk and its temporal variation in patients with normal stress myocardial perfusion scans. What is the warranty period of a normal scan? J Am Coll Cardiol 2003;41:1329–40.
Dakik HA, Kleiman NS, Farmer JA, He Z, Wendt JA, Pratt CM, et al. Intensive medical versus coronary angioplasty for suppression of myocardial ischemia in survivors of acute myocardial infarction. A prospective, randomized pilot study. Circulation 1998;98:2017–23.
O’Keefe JH, Bateman TM, Ligon RW, Case J, Cullon J, Bamhart C, et al. Outcome of medical versus invasive treatment strategies for non-high-risk ischemic heart disease. J Nucl Cardiol 1998;5:28–333.
Hachamovitch R, Hayes SW, Friedman JD, Cohen I, Berman DS. Comparison of the short-term survival benefit associated with revascularization compared with medical therapy in patients with no prior coronary artery disease undergoing stress myocardial perfusion single photon emission computed tomography. Circulation 2003; 107:2900–6.
Gioia G, Milan E, Giubbini R, DePace N, Heo J, Iskandrian AS. Rognostic value of tomographic rest-redistribution thallium 201 imaging in medically treated patients with coronary artery disease and left ventricular dysfunction. J Nucl Cardiol 1996;3:150–6.
Kang X, Berman DS, Lewin HC, Cohen I, Friedman JD, Germans G, et al. Incremental prognostic value of myocardial perfusion single photon emission computed tomography in patients with diabetes mellitus. Am Heart J 1999;138:1025–32.
Hachamovitch R, Berman DS, Shaw LJ, Kiat H, Cohen I, Cabico JA, et al. Incremental prognostic value of myocardial perfusion single photon emission computed tomography for the prediction of cardiac death. Differential stratification for risk of cardiac death and myocardial infarction. Circulation 1998;97:535–43.
Davies RF, Goldberg AD, Forman S, Pepine CJ, Knatternd GL, Geller N, et al. Asymptomatic Cardiac Ischemia Pilot (ACIP) study two-year follow-up: outcomes of patients randomized to initial strategies of medical therapy versus revascularization. Circulation 1997;95:2037–43.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Travin, M.I. The role of stress myocardial perfusion imaging in the risk stratification of patients with remote myocardial infarction. J Nucl Cardiol 11, 656–659 (2004). https://doi.org/10.1016/j.nuclcard.2004.08.005
Issue Date:
DOI: https://doi.org/10.1016/j.nuclcard.2004.08.005